Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer
WBA 10.07.2024

About Gravity Analytica
Recent News
- 01.10.2025 - Walgreens Boots Alliance Reports Fiscal 2025 First Quarter Results
- 01.09.2025 - Walgreens Boots Alliance, Inc. First Quarter 2025 Earnings Conference Call
- 01.02.2025 - Walgreens Boots Alliance Adjusts Fiscal 2025 First Quarter Earnings Announcement to be Held on January 10
Recent Filings
Stenta will lead B2B commercial growth strategy as the company strengthens its role as the first choice for community pharmacy and health services in the
This press release features multimedia. View the full release here:https://www.businesswire.com/news/home/20241007453700/en/

“Jason is a strategic, relationship-driven healthcare leader, and I’m proud to welcome him to the team,” said
Stenta brings nearly 20 years of healthcare experience, successfully leading large organizations and cross-functional teams through growth and change. Most recently, he was at Optum, a UnitedHealth Group company, where he served as SVP, payer sales. Prior to Optum, he held leadership roles at CVS Health for 10 years.
“This is an exciting time at
Stenta will begin his new role in early October.
About
View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241007453700/en/
Source: